Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
06/2012
06/27/2012CN101138550B Mixed glue bundle pharmaceutical preparations produced in combination use of multiple surfactant and processes for their preparation
06/27/2012CN101077350B Compostion and method of treating gonad dysfunction
06/27/2012CN101022822B Liquid preparation of physiologically active peptide
06/26/2012US8209131 Inflammation, allergic diseases, metastatic cancers, pathogen infections; glycosaminoglycan related molecules
06/26/2012US8207293 Peptides derived from maurocalcine used as vectors for intracellular addressing of molecules of interest
06/26/2012US8207264 Functionalized inclusion complexes as crosslinkers
06/26/2012US8207263 Immobilization of membrane proteins onto supports via an amphiphile
06/26/2012US8207234 Methods for treating diabetic foot ulcers
06/26/2012US8207233 Methods for treating diabetic foot ulcers
06/26/2012US8207232 A solid amorphous dispersion of a low-soluble drug and hydroxypropylmethyl celllulose acetate succinate with an ester degree of substitution of 0.85 which results in concentration-enhancement, time release agents, and storage stability; rapid crystal growth inhibitors in supersaturated aqueous solutions
06/26/2012US8207227 Disodium salts, monohydrates, and ethanol solvates for delivering active agents
06/26/2012US8207225 Fatty ester food adjuvant; animal feeds; controlling oxidation to volatile organic compounds; storage stability; oxidation resistance
06/26/2012US8206951 Stabilized liquid anti-RSV antibody formulations
06/26/2012US8206746 Microparticles of water-insoluble substances
06/26/2012US8206744 Branched polyamino acids functionalized with hydrophobic groups, and applications thereof particularly therapeutic applications
06/26/2012US8206739 Fish protein hydrolyzate
06/26/2012US8206735 Pharmaceutical compositions for sustained release delivery of peptides
06/26/2012US8206730 Sunscreen composite particles and porous particles in cosmetic compostions
06/26/2012US8206726 Zwitterionic polysaccharides for promotion of immune system maturation and health
06/26/2012US8206696 viscosity is sufficiently low to allow for easy application and dispensation, but sufficiently high to cause the solution to remain in the area of the wound and not flow away from the prep site; forms a water-resistant film that is fast drying
06/26/2012US8206621 Use of ethanol as plasticizer for preparing subcutaneous implants containing thermolabile active principles dispersed in a PLGA matrix
06/26/2012CA2690490C Pharmaceutical formulations of loratadine for encapsulation and combinations thereof
06/26/2012CA2536185C Drug delivery system by administrating fine particles to sub-tenon
06/26/2012CA2535123C Bioadhesive gel based on hydroxyethylcellulose
06/26/2012CA2458126C Composition for stabilizing hyaluronic acid
06/26/2012CA2443857C Bisphosphonate conjugates and methods of making and using the same
06/26/2012CA2432474C Fibrin binding polypeptides useful inter alia in medical imaging processes
06/26/2012CA2425602C Methods of high-throughput screening for internalizing antibodies
06/26/2012CA2395678C Antimicrobial compositions and methods of use
06/26/2012CA2371689C Preparations for the application of anti-infective and/or anti-inflammatory agents to external or internal parts of the human or animal body in functional and cosmetic tissue remodelling and repair treatment
06/26/2012CA2328614C Matrices for drug delivery and methods for making and using the same
06/26/2012CA2237316C Complex cationic lipids
06/23/2012CA2762530A1 Degradation-stabilised, biocompatible collagen matrices
06/21/2012WO2012083228A1 Biomarkers for assessing sialic acid deficiencies
06/21/2012WO2012083197A1 Water-soluble polymer conjugates of topotecan
06/21/2012WO2012083153A1 Oligomer-containing apremilast moiety compounds
06/21/2012WO2012083138A2 Azole pharmaceutical formulations for parenteral administration and methods for preparing and using the same as treatment of diseases sensitive to azole compounds
06/21/2012WO2012082995A1 Oligomer-containing hydantoin compounds
06/21/2012WO2012081799A1 Polynucleotide delivering complex for target cell
06/21/2012WO2012081676A1 Oxidation reaction product of hop extract, process for production thereof, and use thereof
06/21/2012WO2012081531A1 Disease inhibiting agent
06/21/2012WO2012081273A1 Disease inhibiting agent
06/21/2012WO2012080987A1 Nanoparticles comprising at least one active agent and at least two polyelectrolytes
06/21/2012WO2012080986A1 Process for preparing nanoparticles of two polyamino acids of opposite charge, one of the two of which is in charge surplus
06/21/2012WO2012080976A1 Lar protein-specific ligand
06/21/2012WO2012080915A1 Sterile injectable aqueous formulation used in ophthalmology
06/21/2012WO2012080836A2 Functionalized polymers
06/21/2012WO2012080718A1 Novel pharmaceutical formulation comprising nsaid and cyclodextrin
06/21/2012WO2012080703A1 Pharmaceutical composition comprising imatinib
06/21/2012WO2012080362A1 Preparation comprising insulin, nicotinamide and an amino acid
06/21/2012WO2012080329A1 Formulations of n-(3,5-dichloropyridin-4-yl)-[1-(4-fluorobenzyl)-7-azaindol-3-yl)]glyoxylic acid amide
06/21/2012WO2012080320A1 Fast-acting insulin in combination with long-acting insulin
06/21/2012WO2012079989A1 Compounds for diagnosing diseases associated with the expression of muc5ac
06/21/2012WO2012079979A1 Aqueous factor viii solution
06/21/2012WO2012079582A1 Entrapment of radionuclides in nanoparticle compositions
06/21/2012WO2012054376A3 Metal ion nanoclusters
06/21/2012WO2012052834A3 Multiple unit particulate system comprising metoprolol succinate
06/21/2012WO2012045719A3 New vascular targeting peptides
06/21/2012WO2012040710A3 Stabilized nanobubbles for diagnostic and therapeutic applications
06/21/2012WO2012037078A3 Immunogenic respiratory syncytial virus glycoprotein-containing vlps and related compositions, constructs, and therapeutic methods
06/21/2012WO2012031205A3 Lipid-polymer hybrid particles
06/21/2012WO2012031124A3 Drug formulations using water soluble antioxidants
06/21/2012WO2012031045A3 Phosphonate ester derivatives and methods of synthesis thereof
06/21/2012WO2012027514A3 Compositions and methods for cardiac therapy
06/21/2012US20120158127 Bioabsorbable and biocompatible polyurethanes and polyamides for medical devices
06/21/2012US20120157553 Methods for Using Rebaudioside C as a Flavor Enhancer
06/21/2012US20120157552 Novel concentrated inverse latex, process for preparing it and industrial use thereof
06/21/2012US20120157551 Use of Polymers
06/21/2012US20120157550 Drug carriers comprising amphilphilic block copolymers
06/21/2012US20120157423 Pharmaceutical composition in the form of a gel or a solution based on dihydrotestosterone, process for preparing it and uses thereof
06/21/2012US20120157416 xylitol containing comestible product
06/21/2012US20120157393 Biopolymer, implant comprising it and uses thereof
06/21/2012US20120157318 Use of Branched Copolymers in Polymer Blends
06/21/2012US20120156302 Biodegradable particle and method for producing the same
06/21/2012US20120156280 Myeloid derived suppressor cell inhibiting agents
06/21/2012US20120156271 Composition for cosmetics, cosmetic, method for producing oil-in-water emulsion cosmetic, and two separate layer-type cosmetic
06/21/2012US20120156264 Injectable depot formulation comprising crystals of iloperidone
06/21/2012US20120156261 Disintegrating particle composition and orally rapidly disintegrating tablet
06/21/2012US20120156259 Biodegradable Polyethylene Glycol Based Water-Insoluble Hydrogels
06/21/2012US20120156249 Genetically modified organism for the production of lipids
06/21/2012US20120156176 Thermoresponsive, biodegradable, elastomeric material and uses therefor
06/21/2012US20120156132 Targeting agent to newly formed blood vessels
06/21/2012US20120155620 Personal-Call and Feature Control System and Method for Controlling Telephones, Providing Extended Features for Such Telephones and Routing of Media-Rich Calls
06/21/2012CA2821945A1 Aqueous factor viii solution
06/21/2012CA2821823A1 Azole pharmaceutical formulations for parenteral administration and methods for preparing and using the same as treatment of diseases sensitive to azole compounds
06/21/2012CA2821715A1 Chimeric fibronectin matrix mimetics and uses thereof
06/21/2012CA2821613A1 Preparation comprising insulin, nicotinamide and an amino acid
06/21/2012CA2821411A1 Functionalized polymers
06/21/2012CA2821141A1 Nanoparticles comprising at least one active agent and at least two polyelectrolytes
06/21/2012CA2821138A1 Process for preparing nanoparticles of two polyamino acids of opposite charge, one of the two of which is in charge surplus
06/21/2012CA2821024A1 Entrapment of radionuclides in nanoparticle compositions
06/21/2012CA2820871A1 Disease inhibiting agent
06/21/2012CA2819167A1 Pharmaceutical compositions comprising alisporivir
06/21/2012CA2816155A1 Galactose cluster-pharmacokinetic modulator targeting moiety for sirna
06/21/2012CA2816042A1 Peptide-based in vivo sirna delivery system
06/20/2012EP2465542A1 Oligosaccharide-protein conjugates
06/20/2012EP2465541A1 Improved processes for making hydrazides
06/20/2012EP2465540A1 Disintegrating particle composition and orally rapidly disintegrating tablet
06/20/2012EP2465539A1 Disintegrating particle composition and orally rapidly disintegrating tablet
06/20/2012EP2465520A2 Epitope sequences
1 ... 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 ... 1712